Early Prediction of Primary Non-Response to Infliximab in Crohn’s Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study
Purpose Primary non-response (PNR) occurs in a subset of patients with Crohn’s disease (CD) after infliximab (IFX) induction therapy and remains challenging to identify early. This study aimed to develop and perform preliminary external validation of an early PNR risk stratification model using routinely available clin...